Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Bukwang Pharmaceutical Revenue

Bukwang Pharmaceutical had revenue of 47.78B KRW in the quarter ending March 31, 2026, a decrease of -0.06%. This brings the company's revenue in the last twelve months to 200.68B, up 15.67% year-over-year. In the year 2025, Bukwang Pharmaceutical had annual revenue of 200.71B with 25.38% growth.

• Revenue (ttm): 200.68B
• Revenue Growth: +15.67%
• P/S Ratio: 2.18
• Revenue / Employee: 326.32M
• Employees: 615
• Market Cap: 437.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	200.71B	40.63B	25.38%
Dec 31, 2024	160.09B	34.16B	27.13%
Dec 31, 2023	125.93B	-64.98B	-34.04%
Dec 31, 2022	190.91B	8.42B	4.61%
Dec 31, 2021	182.49B	12.83B	7.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error